Skip to main content
Top
Published in: BMC Neurology 1/2021

Open Access 01-12-2021 | Multiple Sclerosis | Research

Multiple sclerosis projection in Tehran, Iran using Bayesian structural time series

Authors: Payam Amini, Amir Almasi-Hashiani, Mohammad Ali Sahraian, Masood Najafi, Sharareh Eskandarieh

Published in: BMC Neurology | Issue 1/2021

Login to get access

Abstract

Background

The prevalence of Multiple Sclerosis (MS) has been increasing worldwide and the highest prevalence ratio among Asian countries was reported in Iran. This study aims to estimate the increase in MS occurrence during more than three decades in Tehran and forecast the future condition of the disease using time series approaches for the next ten years.

Methods

The cross-sectional study was conducted from 1999 to 2019 based on records of MS cases from Iranian MS Society (IMSS) registry system. The prevalence was estimated using population data presented by the Statistical Centre of Iran. Through Bayesian Structural Time Series (BSTS) model, we want to predict the prevalence of familial and sporadic MS in the next ten years. .

Results

Among 22,421 cases with MS, 16,831 (75.1 %) were female and 5589 (24.9 %) were male. Female to male ratio was 3.0:1 and the number of familial MS cases were 2982 (13.3 %) of subjects. Female gender was less responsible for higher rate of MS in familial definition (beta = 0.020) in comparison to sporadic cases (beta = 0.034). Forecasting by BSTS revealed an increase in MS prevalence for the next ten years so that the prevalence rate for total, familial and sporadic MS respectively begins with 189.50 (183.94-195.14), 25.69 (24.97–26.45) and 163.74(159.06-168.57) in 2020 and ends with 220.84 (171.48-266.92), 30.79 (24.16–37.15), and 189.33(146.97-230.19) in 2029.

Conclusions

According to the findings, MS prevalence increased during three decades and it will increase over the next ten years. Tehran province is one of the regions with highest MS prevalence in Asia. The results of present study indicated that females are at higher risk for MS than males in both sporadic and familial MS.
Literature
1.
go back to reference Dobson R, Giovannoni G. Multiple sclerosis–a review. Eur J Neurol. 2019;26 1:27–40. Dobson R, Giovannoni G. Multiple sclerosis–a review. Eur J Neurol. 2019;26 1:27–40.
2.
go back to reference Shaharabani R, Ram-On M, Talmon Y, Beck R. Pathological transitions in myelin membranes driven by environmental and multiple sclerosis conditions. Proc Natl Acad Sci U S A. 2018;115(44):11156–61. Shaharabani R, Ram-On M, Talmon Y, Beck R. Pathological transitions in myelin membranes driven by environmental and multiple sclerosis conditions. Proc Natl Acad Sci U S A. 2018;115(44):11156–61.
3.
go back to reference Ascherio A. Environmental factors in multiple sclerosis. Expert Rev Neurother. 2013;13(sup2):3–9. Ascherio A. Environmental factors in multiple sclerosis. Expert Rev Neurother. 2013;13(sup2):3–9.
4.
go back to reference Ruano L, Branco M, Severo M, Sousa A, Castelo J, Araújo I, et al. Tracking cognitive impairment in multiple sclerosis using the Brain on Track test: a validation study. Neurol Sci. 2020;41(1):183–91.CrossRef Ruano L, Branco M, Severo M, Sousa A, Castelo J, Araújo I, et al. Tracking cognitive impairment in multiple sclerosis using the Brain on Track test: a validation study. Neurol Sci. 2020;41(1):183–91.CrossRef
5.
go back to reference Li R, Patterson KR, Bar-Or A. Reassessing B cell contributions in multiple sclerosis. Nat Immunol. 2018;19 7:696–707.CrossRef Li R, Patterson KR, Bar-Or A. Reassessing B cell contributions in multiple sclerosis. Nat Immunol. 2018;19 7:696–707.CrossRef
6.
go back to reference Belbasis L, Bellou V, Evangelou E, Ioannidis JP, Tzoulaki I. Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses. Lancet Neurol. 2015;14 3:263–73.CrossRef Belbasis L, Bellou V, Evangelou E, Ioannidis JP, Tzoulaki I. Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses. Lancet Neurol. 2015;14 3:263–73.CrossRef
7.
go back to reference Ghasemi N, Razavi S, Nikzad E. Multiple sclerosis: pathogenesis, symptoms, diagnoses and cell-based therapy. Cell J. 2017;19(1):1.PubMed Ghasemi N, Razavi S, Nikzad E. Multiple sclerosis: pathogenesis, symptoms, diagnoses and cell-based therapy. Cell J. 2017;19(1):1.PubMed
8.
go back to reference Silveira C, Guedes R, Maia D, Curral R, Coelho R. Neuropsychiatric symptoms of multiple sclerosis: state of the art. Psychiatry Investig. 2019;16 12:877.CrossRef Silveira C, Guedes R, Maia D, Curral R, Coelho R. Neuropsychiatric symptoms of multiple sclerosis: state of the art. Psychiatry Investig. 2019;16 12:877.CrossRef
9.
go back to reference Ramari C, Moraes AG, Tauil CB, von Glehn F, Motl R, de David AC. Knee flexor strength and balance control impairment may explain declines during prolonged walking in women with mild multiple sclerosis. Mult Scler Relat Disord. 2018;20:181–5.CrossRef Ramari C, Moraes AG, Tauil CB, von Glehn F, Motl R, de David AC. Knee flexor strength and balance control impairment may explain declines during prolonged walking in women with mild multiple sclerosis. Mult Scler Relat Disord. 2018;20:181–5.CrossRef
10.
go back to reference Palace J, Duddy M, Bregenzer T, Lawton M, Zhu F, Boggild M, et al. Effectiveness and cost-effectiveness of interferon beta and glatiramer acetate in the UK Multiple Sclerosis Risk Sharing Scheme at 6 years: a clinical cohort study with natural history comparator. Lancet Neurol. 2015;14 5:497–505.CrossRef Palace J, Duddy M, Bregenzer T, Lawton M, Zhu F, Boggild M, et al. Effectiveness and cost-effectiveness of interferon beta and glatiramer acetate in the UK Multiple Sclerosis Risk Sharing Scheme at 6 years: a clinical cohort study with natural history comparator. Lancet Neurol. 2015;14 5:497–505.CrossRef
11.
go back to reference Walton C, King R, Rechtman L, Kaye W, Leray E, Marrie RA, et al. Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS. Mult Scler J. 2020;26 14:1816–21.CrossRef Walton C, King R, Rechtman L, Kaye W, Leray E, Marrie RA, et al. Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS. Mult Scler J. 2020;26 14:1816–21.CrossRef
12.
go back to reference Yamout BI, Assaad W, Tamim H, Mrabet S, Goueider R. Epidemiology and phenotypes of multiple sclerosis in the Middle East North Africa (MENA) region. Multiple Sclerosis Journal–Experimental. Transl Clin. 2020;6 1:2055217319841881. Yamout BI, Assaad W, Tamim H, Mrabet S, Goueider R. Epidemiology and phenotypes of multiple sclerosis in the Middle East North Africa (MENA) region. Multiple Sclerosis Journal–Experimental. Transl Clin. 2020;6 1:2055217319841881.
13.
go back to reference Heydarpour P, Khoshkish S, Abtahi S, Moradi-Lakeh M, Sahraian MA. Multiple sclerosis epidemiology in Middle East and North Africa: a systematic review and meta-analysis. Neuroepidemiology. 2015;44(4):232–44. Heydarpour P, Khoshkish S, Abtahi S, Moradi-Lakeh M, Sahraian MA. Multiple sclerosis epidemiology in Middle East and North Africa: a systematic review and meta-analysis. Neuroepidemiology. 2015;44(4):232–44.
14.
go back to reference Eskandarieh S, Molazadeh N, Moghadasi AN, Azimi AR, Sahraian MA. The prevalence, incidence and familial recurrence of multiple sclerosis in Tehran, Iran. Mult Scler Relat Disord. 2018;25:143.CrossRef Eskandarieh S, Molazadeh N, Moghadasi AN, Azimi AR, Sahraian MA. The prevalence, incidence and familial recurrence of multiple sclerosis in Tehran, Iran. Mult Scler Relat Disord. 2018;25:143.CrossRef
15.
go back to reference Almasi-Hashiani A, Sahraian MA, Eskandarieh S. Evidence of an increased prevalence of multiple sclerosis: a population-based study of Tehran registry during 1999–2018. BMC Neurol. 2020;20:1–7.CrossRef Almasi-Hashiani A, Sahraian MA, Eskandarieh S. Evidence of an increased prevalence of multiple sclerosis: a population-based study of Tehran registry during 1999–2018. BMC Neurol. 2020;20:1–7.CrossRef
16.
go back to reference Salehi Z, Almasi-Hashiani A, Sahraian MA, Eskandarieh S. Epidemiology of familial multiple sclerosis: A population-based study in Tehran during 1999–2018. Mult Scler Relat Disord. 2020;43:102178.CrossRef Salehi Z, Almasi-Hashiani A, Sahraian MA, Eskandarieh S. Epidemiology of familial multiple sclerosis: A population-based study in Tehran during 1999–2018. Mult Scler Relat Disord. 2020;43:102178.CrossRef
17.
go back to reference Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162–73.CrossRef Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162–73.CrossRef
18.
go back to reference Rincon DR, Leach B, Pollard J, Parkinson S, Gkousis E, Lichten CA, et al. Exploring the Societal Burden of Multiple Sclerosis: A Study Into the Non-clinical Impact of the Disease, Including Changes with Progression. RAND; 2019. Rincon DR, Leach B, Pollard J, Parkinson S, Gkousis E, Lichten CA, et al. Exploring the Societal Burden of Multiple Sclerosis: A Study Into the Non-clinical Impact of the Disease, Including Changes with Progression. RAND; 2019.
19.
go back to reference Nasiri M, Maroufi H, Sahraian MA, Eskandarieh S. Prevalence of multiple sclerosis and its risks in Tehran, Iran, in 2019. Neurol Sci. 2021;42(6):2575–76. Nasiri M, Maroufi H, Sahraian MA, Eskandarieh S. Prevalence of multiple sclerosis and its risks in Tehran, Iran, in 2019. Neurol Sci. 2021;42(6):2575–76.
20.
go back to reference Bounceur N, Hoteit I, Knio O. A Bayesian Structural Time Series Approach for Predicting Red Sea Temperatures. IEEE J Select Topics Appl Earth Observ Remote Sensing. 2020;13:1996–2009.CrossRef Bounceur N, Hoteit I, Knio O. A Bayesian Structural Time Series Approach for Predicting Red Sea Temperatures. IEEE J Select Topics Appl Earth Observ Remote Sensing. 2020;13:1996–2009.CrossRef
21.
go back to reference Brodersen KH, Gallusser F, Koehler J, Remy N, Scott SL. Inferring causal impact using Bayesian structural time-series models. Ann Appl Stat. 2015;9:1:247-74.CrossRef Brodersen KH, Gallusser F, Koehler J, Remy N, Scott SL. Inferring causal impact using Bayesian structural time-series models. Ann Appl Stat. 2015;9:1:247-74.CrossRef
23.
go back to reference Scott SL, Scott MSL, Scott MS, BoomSpikeSlab D, Boom L. Package ‘bsts’. 2020. Scott SL, Scott MSL, Scott MS, BoomSpikeSlab D, Boom L. Package ‘bsts’. 2020.
24.
go back to reference Eskandarieh S, Heydarpour P, Minagar A, Pourmand S, Sahraian MA. Multiple sclerosis epidemiology in east Asia, south east Asia and south Asia: a systematic review. Neuroepidemiology. 2016;46(3):209–21.CrossRef Eskandarieh S, Heydarpour P, Minagar A, Pourmand S, Sahraian MA. Multiple sclerosis epidemiology in east Asia, south east Asia and south Asia: a systematic review. Neuroepidemiology. 2016;46(3):209–21.CrossRef
25.
go back to reference Azami M, YektaKooshali MH, Shohani M, Khorshidi A, Mahmudi L. Epidemiology of multiple sclerosis in Iran: A systematic review and meta-analysis. PLoS ONE. 2019;14 4:e0214738.CrossRef Azami M, YektaKooshali MH, Shohani M, Khorshidi A, Mahmudi L. Epidemiology of multiple sclerosis in Iran: A systematic review and meta-analysis. PLoS ONE. 2019;14 4:e0214738.CrossRef
26.
go back to reference Abdollahpour I, Nedjat S, Mansournia MA, Sahraian MA, Asgari N. Parental ethnicity associated with risk for multiple sclerosis: A population-based incident case–control study in Iran. Mult Scler Relat Disord. 2018;20:100–3.CrossRef Abdollahpour I, Nedjat S, Mansournia MA, Sahraian MA, Asgari N. Parental ethnicity associated with risk for multiple sclerosis: A population-based incident case–control study in Iran. Mult Scler Relat Disord. 2018;20:100–3.CrossRef
27.
go back to reference Albor C, du Sautoy T, Kali Vanan N, Turner BP, Boomla K, Schmierer K. Ethnicity and prevalence of multiple sclerosis in east London. Mult Scler J. 2017;23 1:36–42.CrossRef Albor C, du Sautoy T, Kali Vanan N, Turner BP, Boomla K, Schmierer K. Ethnicity and prevalence of multiple sclerosis in east London. Mult Scler J. 2017;23 1:36–42.CrossRef
28.
go back to reference Hosseinzadeh A, Baneshi MR, Sedighi B, Kermanchi J, Haghdoost AA. Geographic variations of multiple sclerosis in Iran: a population based study. Mult Scler Relat Disord. 2019;28:244–9.CrossRef Hosseinzadeh A, Baneshi MR, Sedighi B, Kermanchi J, Haghdoost AA. Geographic variations of multiple sclerosis in Iran: a population based study. Mult Scler Relat Disord. 2019;28:244–9.CrossRef
29.
go back to reference Bergamaschi R. Prognostic factors in multiple sclerosis. Int Rev Neurobiol. 2007;79:423–47.CrossRef Bergamaschi R. Prognostic factors in multiple sclerosis. Int Rev Neurobiol. 2007;79:423–47.CrossRef
30.
go back to reference Sintzel MB, Rametta M, Reder AT. Vitamin D and multiple sclerosis: a comprehensive review. Neurol Ther. 2018;7 1:59–85.CrossRef Sintzel MB, Rametta M, Reder AT. Vitamin D and multiple sclerosis: a comprehensive review. Neurol Ther. 2018;7 1:59–85.CrossRef
31.
go back to reference Knudsen G, Harbo HF, Smestad C, Celius EG, Åkesson E, Oturai A, et al. X chromosome inactivation in females with multiple sclerosis. Eur J Neurol. 2007;14(12):1392–6. Knudsen G, Harbo HF, Smestad C, Celius EG, Åkesson E, Oturai A, et al. X chromosome inactivation in females with multiple sclerosis. Eur J Neurol. 2007;14(12):1392–6.
32.
go back to reference Sellebjerg F, Krakauer M, Khademi M, Olsson T, Sørensen P. FOXP 3, CBLB and ITCH gene expression and cytotoxic T lymphocyte antigen 4 expression on CD 4 + CD 25high T cells in multiple sclerosis. Clin Exp Immunol. 2012;170(2):149–55.CrossRef Sellebjerg F, Krakauer M, Khademi M, Olsson T, Sørensen P. FOXP 3, CBLB and ITCH gene expression and cytotoxic T lymphocyte antigen 4 expression on CD 4 + CD 25high T cells in multiple sclerosis. Clin Exp Immunol. 2012;170(2):149–55.CrossRef
33.
go back to reference Harbo HF, Gold R, Tintoré M. Sex and gender issues in multiple sclerosis. Ther Adv Neurol Disord. 2013;6 4:237–48.CrossRef Harbo HF, Gold R, Tintoré M. Sex and gender issues in multiple sclerosis. Ther Adv Neurol Disord. 2013;6 4:237–48.CrossRef
34.
go back to reference Baldur-Felskov B, Kjaer S, Albieri V, Steding-Jessen M, Kjaer T, Johansen C, et al. Psychiatric disorders in women with fertility problems: results from a large Danish register-based cohort study. Hum Reprod . 2013;28 3:683–90.CrossRef Baldur-Felskov B, Kjaer S, Albieri V, Steding-Jessen M, Kjaer T, Johansen C, et al. Psychiatric disorders in women with fertility problems: results from a large Danish register-based cohort study. Hum Reprod . 2013;28 3:683–90.CrossRef
35.
go back to reference Maroufizadeh S, Navid B, Omani-Samani R, Amini P. The effects of depression, anxiety and stress symptoms on the clinical pregnancy rate in women undergoing IVF treatment. BMC Res Notes. 2019;12(1):1–4.CrossRef Maroufizadeh S, Navid B, Omani-Samani R, Amini P. The effects of depression, anxiety and stress symptoms on the clinical pregnancy rate in women undergoing IVF treatment. BMC Res Notes. 2019;12(1):1–4.CrossRef
36.
go back to reference Steenhof M, Stenager E, Nielsen NM, Kyvik K, Möller S, Hertz JM. Familial multiple sclerosis patients have a shorter delay in diagnosis than sporadic cases. Mult Scler Relat Disord. 2019;32:97–102.CrossRef Steenhof M, Stenager E, Nielsen NM, Kyvik K, Möller S, Hertz JM. Familial multiple sclerosis patients have a shorter delay in diagnosis than sporadic cases. Mult Scler Relat Disord. 2019;32:97–102.CrossRef
37.
go back to reference Tipirneni A, Weinstock-Guttman B, Ramanathan M, Abdelrahman N, Hussein S, Hagemeier J, et al. MRI characteristics of familial and sporadic multiple sclerosis patients. Mult Scler J. 2013;19 9:1145–52.CrossRef Tipirneni A, Weinstock-Guttman B, Ramanathan M, Abdelrahman N, Hussein S, Hagemeier J, et al. MRI characteristics of familial and sporadic multiple sclerosis patients. Mult Scler J. 2013;19 9:1145–52.CrossRef
38.
go back to reference Hader WJ, Yee IM. The prevalence of familial multiple sclerosis in saskatoon, Saskatchewan. Mult Scler Int. 2014;2014:545080. Hader WJ, Yee IM. The prevalence of familial multiple sclerosis in saskatoon, Saskatchewan. Mult Scler Int. 2014;2014:545080.
39.
go back to reference Steenhof M, Nielsen NM, Stenager E, Kyvik K, Möller S, Hertz JM. Distribution of disease courses in familial vs sporadic multiple sclerosis. Acta Neurol Scand. 2019;139 3:231–7.CrossRef Steenhof M, Nielsen NM, Stenager E, Kyvik K, Möller S, Hertz JM. Distribution of disease courses in familial vs sporadic multiple sclerosis. Acta Neurol Scand. 2019;139 3:231–7.CrossRef
40.
go back to reference Rojas J, Patrucco L, MIguez J, Sinay V, Cassara FP, Cáceres F, et al. Disease onset in familial and sporadic multiple sclerosis in Argentina. Mult Scler Relat Disord. 2016;6:54–6.CrossRef Rojas J, Patrucco L, MIguez J, Sinay V, Cassara FP, Cáceres F, et al. Disease onset in familial and sporadic multiple sclerosis in Argentina. Mult Scler Relat Disord. 2016;6:54–6.CrossRef
41.
go back to reference Mousavizadeh A, Dastoorpoor M, Naimi E, Dohrabpour K. Time-trend analysis and developing a forecasting model for the prevalence of multiple sclerosis in Kohgiluyeh and Boyer-Ahmad Province, southwest of Iran. Public Health. 2018;154:14–23.CrossRef Mousavizadeh A, Dastoorpoor M, Naimi E, Dohrabpour K. Time-trend analysis and developing a forecasting model for the prevalence of multiple sclerosis in Kohgiluyeh and Boyer-Ahmad Province, southwest of Iran. Public Health. 2018;154:14–23.CrossRef
42.
go back to reference Heydarpour P, Amini H, Khoshkish S, Seidkhani H, Sahraian MA, Yunesian M. Potential impact of air pollution on multiple sclerosis in Tehran, Iran. Neuroepidemiology. 2014;43(3–4):233–8.CrossRef Heydarpour P, Amini H, Khoshkish S, Seidkhani H, Sahraian MA, Yunesian M. Potential impact of air pollution on multiple sclerosis in Tehran, Iran. Neuroepidemiology. 2014;43(3–4):233–8.CrossRef
Metadata
Title
Multiple sclerosis projection in Tehran, Iran using Bayesian structural time series
Authors
Payam Amini
Amir Almasi-Hashiani
Mohammad Ali Sahraian
Masood Najafi
Sharareh Eskandarieh
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2021
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-021-02281-x

Other articles of this Issue 1/2021

BMC Neurology 1/2021 Go to the issue